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Introduction
Chronic low back pain (LBP) is a major global health problem for which current treatments achieve limited success [1] . The recalcitrant nature of chronic LBP, along with the growing recognition of involvement of many supraspinal centers, including the sensorimotor regions of the cortex in its pathophysiology [2] , has led to the investigation of neuromodulatory techniques (e.g., transcranial direct current stimulation [tDCS] and peripheral electrical stimulation [PES] ) that may alter cortical excitability to produce greater effects on chronic pain than traditional therapy. However, evidence for an effect of neuromodulation on chronic pain is conflicting, with some systematic reviews reporting beneficial effects whereas others report no change [3] [4] [5] [6] [7] . One issue is that stimulation is frequently based on protocols developed in healthy individuals without a clear understanding of the neurophysiological effects of stimulation in people with pain [3] . Finding a marker of whether a neuromodulatory treatment is "active" (i.e., produces a neural response likely to lead to benefits on pain and function) in people with chronic LBP is important if neuromodulation is to be optimized for therapy, patient/ treatment matching is to be improved, and questions of clinical effectiveness are to be resolved.
The primary motor cortex (M1) is emerging as one of the most effective target regions in the treatment of pain and is the most commonly stimulated region in studies of chronic pain [8] . Although the stimulus is unlikely to be localized to the M1 regions and the precise mechanism remains unclear, neuromodulatory techniques are thought to induce analgesic effects through immediate and long-lasting changes in M1 excitability that produce widespread, network effects in outer brain areas (e.g., orbitofrontal cortex), remote inner brain areas (e.g., thalamus, periaqueductal grey), and cortical areas (e.g., S1 and insula; for a review of mechanisms, see [8] ). In an attempt to find a neurophysiological marker of cortical changes induced by neuromodulation, transcranial magnetic stimulation (TMS) has been used to assess M1 excitability in response to anodal tDCS and PES [9] [10] [11] [12] [13] . However, although anodal tDCS is generally thought to increase, and high-intensity PES to decrease, M1 excitability, interindividual variability is high (e.g., [10] [11] [12] [13] ). In addition, studies using other forms of neuromodulation, such as repetitive transcranial magnetic stimulation (rTMS), have shown that the changes induced in M1 excitability differ between healthy individuals and those with chronic pain [14] [15] [16] . Despite this, no study has examined the neurophysiological response induced by anodal tDCS and PES in people with chronic LBP.
Here we aimed to compare the effect of three neuromodulatory protocols: 1) anodal tDCS, 2) high-intensity PES, and 3) a priming protocol where PES and tDCS were combined on M1 excitability in people with chronic LBP and pain-free controls. Basic research of homeostatic mechanisms (that operate to limit extreme changes in potentiation or depression, thus maintaining a steady state [17] ) has led to the proposal that an intervention that reduces M1 excitability (e.g., PES) may better "prime" the nervous system for an excitatory tDCS treatment, thus producing a greater increase in M1 excitability than can be achieved with tDCS alone. In a preliminary clinical trial, this combination of modalities produced greater effects on pain and disability reported by patients with chronic LBP than either tDCS or PES applied alone [18] . Thus, we also aimed to determine whether manipulating M1 excitability prior to neuromodulation altered an individual's neurophysiological response to anodal tDCS applied alone. We hypothesized that anodal tDCS would increase M1 excitability, PES would decrease M1 excitability, and the combined stimulation protocol would increase M1 excitability to a greater extent than tDCS applied alone and that this would occur in both groups.
Methods

Participants
Ten right-handed individuals with recurring episodes of nonspecific LBP and 10 age-and sex-matched controls with no history of persistent pain participated. Data for some map parameters have been reported previously for the participants with LBP as part of a larger study of treatment [18] . Participants in both groups were naïve to the tDCS and PES protocols. Individuals with LBP were included if they had experienced episodic pain in their low back (with or without buttock pain) for more than three months that limited function and was accompanied by pain rated greater than 3 on an 11-point numerical rating scale (NRS), anchored with "no pain" at 0 and "worst pain imaginable" at 10. Participants were to have experienced at least two episodes of pain in the last 12 months, with each episode lasting longer than one week. Participant characteristics are provided in Table 1 . Individuals were excluded from participation if they had a history of major circulatory, neurological, or psychiatric conditions, previous spinal surgery, recent or current pregnancy, analgesic or anti-inflammatory medication in the last month, or had received treatment for their back pain from a health professional in the last month. All procedures were approved by the institutional medical research ethics committee and conformed to the Declaration of Helsinki. Participants provided written informed consent.
Experimental Protocol
Four 30-minute interventions were delivered across separate sessions on different days (no less than seven days apart) in random order: 1) concurrent anodal 
Electromyography
Surface electromyography (EMG) was recorded using silver-silver chloride disposable electrodes positioned 3 cm lateral to the spinous process of L3 on the side of worst pain (for the age-and gender-matched pain-free controls, the same side was assessed) [19, 20] . The ground electrode was positioned over the anterior superior iliac spine. EMG data were amplified 1,000Â, band pass filtered at 20 to 1,000 Hz, and sampled at 2,000 Hz using a Micro1401 data acquisition system and Spike2 software (Cambridge Electronic Design, Cambridge, UK).
Interventions
Interventions were applied for 30 minutes based on research that demonstrates reduced cortical excitability after 30 minutes of PES [21] and tDCS articles in the literature that typically use application times of between 20 and 40 minutes [22] .
Transcranial Direct Current Stimulation
Anodal tDCS was delivered to the primary motor cortex (M1) via two 35-cm 2 (5Â7 cm) saline-soaked surface sponge electrodes using a direct current stimulator (constant current of 1 mA; DC stimulator plus; Magstim, UK). Based on previous studies of the motor cortical representation of the back muscles [23, 24] , the center of the active electrode was positioned over the approximate location of the motor cortical representation of the back muscles (1 cm anterior and 4 cm lateral to the vertex) contralateral to the side of worst pain (or the matched side for pain-free controls), and the reference electrode was positioned over the contralateral supraorbital region. Current intensity was ramped up (0 mA to 1 mA) and down (1 mA to 0 mA) over 10 seconds at the beginning and end of the 30-minute stimulation period. A current of 1 mA was selected as previous studies have shown that at this intensity participants can be effectively blinded to stimulation condition [25] . For sham tDCS, electrodes were placed in an identical position to that used for active stimulation. Stimulation was turned on for 15 seconds and then off to provide participants with the initial itching sensation but without current for the remainder of the "stimulation" period.
Peripheral Electrical Stimulation
PES was applied to the area of worst pain in individuals with LBP or the matched side of pain-free controls through the same electrodes used for recording EMG (Chattanooga Intelect Advanced therapy system, Chattanooga Group, Vista, USA). Stimulation was delivered using the following parameters: biphasic wave form (0.1-ms pulse duration), frequency of 2 Hz, 30-minute duration, stimulation intensity of 2-3Â the perceptual threshold, sufficient to produce a strong, tingling sensation just below the pain threshold. These parameters are commonly used in rehabilitation settings for the treatment of chronic pain and have been shown to reduce corticomotor excitability in healthy individuals and people with cLBP [7, 18, 21, 26, 27] . Habituation to the stimulus was monitored, and the intensity adjusted accordingly. The same electrode position was used for sham PES. The machine was turned on and all treatment parameters set, but stimulus intensity was set to 0 mA. To ensure blinding, participants were told that different stimulus intensities were being investigated and they may or may not perceive sensations during the intervention [28] .
Outcome Measures
Motor Cortex Mapping
Single-pulse transcranial magnetic stimulation (TMS) was delivered to the primary motor cortex contralateral to the side of worst pain or the matched side for pain-free controls (Magstim 200 stimulator/figure-of-eight coil; Magstim Co. Ltd., Dyfed, UK) following a previously described protocol [29] [30] [31] . In brief, the coil was positioned along the sagittal plane with the handle facing posteriorly. Five magnetic stimuli were delivered at 1-cm intervals on a 6Â7 cm grid starting at the vertex (0-5 cm lateral and -1 cm posterior to 5 cm anterior, where the vertex is point 0.0 cm). Accurate coil placement was determined using neuronavigation (Rogue Resolutions Ltd, Cardiff, UK). As in previous studies, it was not possible to elicit clear and reliable Motor Evoked Potentials (MEPs) from the paraspinal muscles at rest [24, 31] ; thus, stimuli were applied at 100% of stimulator output with an interstimulus interval of six seconds, and the paraspinal muscles were activated to 20% of their maximum voluntary contraction (MVC) EMG (highest root-mean-square EMG for one second following three three-second paraspinal MVCs performed against resistance in sitting). Visual feedback was provided on a computer monitor [20, 32] . To minimize fatigue, participants rested for three to five minutes following completion of each row of stimuli (0-5 cm lateral). To ensure that prolonged sitting and high TMS stimulator output required during the mapping procedure did not exacerbate LBP symptoms, pain severity was monitored verbally throughout and evaluated on completion of TMS mapping using an 11-point NRS. All TMS procedures adhered to the TMS checklist for methodological quality [33] .
Data Analyses
Analysis of TMS data was performed using MATLAB 7 (The Mathsworks, USA) according to a standard protocol [18, 31] . EMG was full-wave rectified, and the five MEPs at each scalp site were averaged. MEP onset and offset were visually identified from the averaged traces, and the MEP amplitude was calculated as the root-mean-square EMG amplitude between the onset and offset. Background EMG from 55 to 5 ms prior to stimulation was subtracted. MEP amplitudes were superimposed over the respective scalp sites to produce a topographical representation of the target paraspinal muscle and normalized to the peak amplitude of the baseline map for each intervention. Normalized values that were less than 25% of the peak response were removed, and the remaining values rescaled from 0% to 100%.
Three parameters were extracted from TMS mapping data: 1) map volume (a measure of the total excitability of the cortical representation) was calculated as the sum of the mean normalized MEP amplitude at all active sites, 2) the number of discrete peaks in each map was determined according to previously published criteria [18, 31] , and 3) the CSP was calculated as the period from TMS onset until the resumption of continuous EMG at prestimulus levels and summed to produce an average CSP value for each map.
Statistical Analyses
Data were assessed for normality using Shapiro-Wilks tests. Baseline data for map volume, number of map peaks, and CSP from all four protocols were compared between groups (LBP, control) using separate one-way analyses of variance (ANOVAs). Map volume, number of map peaks, and CSP were compared between groups (LBP, control) and time points (pre, post) for each intervention (tDCS/PES, tDCS alone, PES alone, and sham) using four separate two-way repeated measures ANOVAs. Significant interactions were further explored using Holm-Sidak post hoc tests adjusted for multiple comparisons. Significance was set at a P value of less than 0.05.
Results
There was no difference in pain severity following the mapping procedure (premapping 4.262.2; postmapping 3.262.3) for people with chronic LBP, suggesting that prolonged sitting did not aggravate symptoms in these individuals.
Map Volume
There was no difference in map volume at baseline between individuals with LBP and pain-free controls (P ¼ 0.37). The combined tDCS/PES intervention (interaction: group Â time P ¼ 0.005) increased map volume in individuals with LBP (post hoc: P < 0.001) but not in pain-free controls (post hoc: P ¼ 0.73) (Figure 1) . Conversely, tDCS applied alone (interaction: group Â time P ¼ 0.045) did not alter map volume in individuals with LBP (post hoc: P ¼ 0.78), but increased map volume in pain-free controls (post hoc: P ¼ 0.004). Map volume reduced in both groups when PES was applied alone (main effect: time P ¼ 0.013; interaction: group Â time P ¼ 0.96). The sham condition did not alter map volume in either group (interaction: group Â time P ¼ 0.96; main effect: time P ¼ 0.98). The response of each individual to the four neuromodulatory interventions is given in Figure 2 .
Discrete Map Peaks
The number of discrete peaks in the cortical map was less at baseline in those with LBP than pain-free controls (P < 0.001), with 1.3 6 0.6 peaks observed in the maps of individuals with LBP and 2.0 6 0.6 peaks observed in control maps. Following the combined tDCS/PES intervention, the number of discrete map peaks increased in participants with LBP (interaction: group Â time P ¼ 0.003; post hoc: P < 0.001; 1.9 6 0.31 peaks) but remained unchanged in controls (post hoc: P ¼ 1.0; 2.0 6 0.5 peaks). Although there was a trend toward statistical significance, the number of discrete map peaks was unaltered in either group following tDCS applied alone (interaction: group Â time P ¼ 0.022; main effect: time P ¼ 0.79; post hoc: P ¼ 0.068), PES applied alone (interaction: group Â time P ¼ 0.12; main effect: time P ¼ 0.75), or the sham intervention (interaction: group Â time P ¼ 0.67; main effect: time P ¼ 1.0).
Cortical Silent Period Duration
The duration of the CSP was similar at baseline in both groups (P ¼ 0.21). However, following the combined tDCS/PES intervention (interaction: group Â time P ¼ 0.009), the duration of the CSP was reduced in individuals with LBP (post hoc: P < 0.001) but not in painfree controls (post hoc: P ¼ 0.86) (Figure 3 ). tDCS applied alone also reduced the CSP duration but only in control subjects (interaction: group Â time P ¼ 0.043; post hoc: controls P ¼ 0.014; LBP P ¼ 0.69). The duration of the CSP was reduced in both groups following PES applied alone (main effect: time P ¼ 0.022; interaction: group Â time P ¼ 0.77). There was no change in the CSP in either group with the sham intervention (interaction: group Â time P ¼ 0.93).
Discussion
This preliminary study is the first to investigate the M1 response to three active neuromodulatory interventions and a sham in individuals with chronic LBP and the first to compare this response to that of healthy, pain-free controls. These data provide evidence that anodal tDCS does not produce an increase in M1 excitability in chronic LBP, which contrasts the increase observed in pain-free controls. PES reduced M1 excitability similarly for both groups. The interaction between treatments differed between groups; combined treatment increased M1 excitability in the chronic LBP group but had no effect in controls. If the volume of the cortical map and CSP revealed by TMS are interpreted as a marker of general excitability of neural processes in M1, then these data suggest that if the goal of treatment is to increase M1 excitability in individuals with chronic LBP, a priming protocol (e.g., combined PES and anodal tDCS) may be necessary, rather than tDCS applied alone. Understanding the neurophysiological effects of neuromodulation in people with pain is important to guide patient/treatment matching and improve treatment success.
Our data show decreased map volume and CSP in the M1 contralateral to the side of pain (or the matched side in pain-free controls) following PES in those with and without LBP. These results are consistent with previous studies in healthy individuals [9, 21, 34] . However, the response to anodal tDCS applied alone differed between groups; whereas map volume increased and CSP decreased in healthy individuals (consistent with increased M1 excitability), neither parameter changed in the chronic LBP group. Considering that tDCS will spread beyond M1 to other regions, this finding implies that direct M1 stimulation or indirect effects from other regions do not have the same effects on M1 excitability between healthy individuals and those with chronic LBP. A novel observation was an increase in map volume, an increase in the number of discrete map peaks, and a decrease in the CSP in the chronic LBP group when anodal tDCS and PES were combined. No effect of the combined stimulation was observed in healthy individuals. One explanation for the difference in response between groups is that people with chronic LBP might have a disturbance of homeostatic metaplasticity that reduces neural responsiveness to excitatory neuromodulation such as anodal tDCS. Theories of homeostatic metaplasticity propose that individual synapses undergo bidirectional plasticity; that is, an individual synapse can undergo both long-term potentiation (LTP; synaptic strengthening) and long-term depression (LTD; synaptic weakening) [35] . The threshold for induction of LTP or LTD is adjusted by homeostatic mechanisms to ensure that neural activity remains within a stable, dynamic range over time. Animal and human studies have shown that homeostatic metaplasticity regulates the balance between LTP and LTD in the healthy brain [35] , and there is early evidence that these mechanisms may be disturbed in chronic pain conditions such as migraine [36, 37] . In theory, a greater threshold for LTP-like plasticity (reduced threshold for inhibitory homeostatic mechanisms) could be a protective response to avoid "runaway" LTP in response to ongoing stimuli (in this case, pain). For example, a greater threshold for LTP-like plasticity is observed in migraine patients with higher attack frequency [36, 37] . This is hypothesized as a protective mechanism to prevent exaggerated LTP and the occurrence of further attacks in response to endogenous and exogenous stimuli (i.e., headache "triggers"). Although not directly examined in the current study, it is plausible that a similar mechanism may exist in chronic LBP to prevent "runaway" LTP in response to ongoing pain.
A hypothesis of disturbed homeostatic metaplasticity in chronic LBP might also explain why a greater increase in corticomotor excitability was observed when depressive PES was combined with excitatory anodal tDCS than when tDCS was applied alone. The application of a depressive neuromodulatory intervention (e.g., PES) might have "primed" relevant neural circuits sliding the synapse toward LTD. This in turn might reduce the threshold for LTP, restoring the normal excitatory response to anodal tDCS. If this is the case, then the brains of people with chronic LBP may need to be primed to optimally respond to treatments that induce LTP (e.g., anodal tDCS, motor retraining). It is not clear why priming in pain-free controls did not induce an excitatory response. One possibility is that healthy controls with normal homeostatic mechanisms may not require priming in order to reach the "ceiling" of their excitatory response. Further studies are required to clarify the interaction between neuromodulation and neural activity in both the healthy brain and those with chronic pain.
An alternative explanation for the current findings is that PES helped to focus attention to the back region in people with chronic pain, enhancing the excitatory effects of anodal tDCS. In people with chronic LBP, body image and tactile acuity of the back are disrupted [38] . As attention is known to be an important feature of plasticity induction, the application of PES to the back might have increased awareness of this region in people with pain, facilitating the effects of anodal tDCS. A similar effect may not have been observed in healthy individuals who have normal body image and tactile acuity of the back.
Understanding the neurophysiological response to neuromodulation has implications for the design and implementation of neuromodulatory treatments in people with chronic pain. The effectiveness of neuromodulation is likely to depend on the degree of M1 excitability present prior to stimulation [16] , yet most previous studies of neuromodulation in chronic LBP have not included evaluation of the neurophysiological response to treatment [23, 39, 40] . This renders it impossible to know whether neuromodulation induced a neurophysiological response that could reasonably lead to analgesia. As such, further work is needed to identify an optimal marker of whether a treatment has induced the desired neurophysiological effect and to understand the mechanisms through which neuromodulation may influence pain. This information is likely to assist identification of responders and nonresponders to neuromodulatory treatments. Indeed, early evidence suggests that an individual's response to transcranial magnetic stimulation may predict their response to some neuromodulatory techniques [11, 41, 42] .
This study provides the first preliminary investigation of the neurophysiological response to neuromodulation in Figure 3 Cortical silent period (CSP) duration (group data; mean and standard error) of the back muscles contralateral to the site of stimulation (site of worst pain in low back pain [LBP] or same side for matched control) before (black bars) and after (gray bars) each intervention in individuals with LBP and pain-free controls. CSP duration reduced in individuals with LBP in response to the combined transcranial direct current stimulation (tDCS)/peripheral electrical stimulation (PES) intervention and in pain-free controls when tDCS was applied alone. CSP duration reduced in both groups following PES applied alone. *P < 0.05. LBP ¼ low back pain; PES ¼ peripheral electrical stimulation; tDCS ¼ transcranial direct current stimulation. chronic LBP. However, interindividual variability in the M1 response to neuromodulation is known to be high, and this study is limited by the small sample size. Our data suggest that the neurophysiological response to anodal tDCS may be more variable in people with chronic LBP than the response to PES. However, this early finding requires more detailed investigation. Future studies should evaluate the neurophysiological response to neuromodulation in a larger population of people with chronic LBP and seek to determine whether baseline levels of M1 excitability predict the neurophysiological and clinical response to treatment. Finally, we selected tDCS and PES over other forms of neuromodulation based on their clinical utility (both techniques are portable, inexpensive, and safe).
Conclusions
This study is the first to examine the neurophysiological response to different neuromodulatory techniques in people with chronic LBP. Our data suggest that if the goal of treatment is to increase M1 excitability, a priming protocol (e.g., combined PES þ tDCS) may be more effective than tDCS alone. Further investigation of the neurophysiological response to neuromodulation in people with pain is required to determine who is likely to respond to this type of treatment and to guide and inform the optimal neuromodulatory intervention for each individual.
